Synapse - Works

Results (52)

Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): Phase 2 results from an open-label, single arm, multicentre phase 1/2 trial

Journal Article

Rubinstein, P. G.; Moore, P. C.; Bimali, M.; Lee, J. Y.; Rudek, M. A.; Chadburn, A.; Ratner, L.; Henry, D. H.; Cesarman, E.; DeMarco, C. E.; more...
The Lancet Haematology (2023)

Fulltext@MSK | Save

Validation of a high-sensitivity assay for detection of chimeric antigen receptor T-cell vectors using low-partition digital PCR technology

Journal Article

Arcila, M. E.; Patel, U.; Momeni-Boroujeni, A.; Yao, J.; Chan, R.; Chan, J.; Rijo, I.; Yu, W.; Chaves, N.; Patel, H.; more...
Journal of Molecular Diagnostics (2023)

Fulltext@MSK | Save

Giant cell myocarditis after mogamulizumab

Meeting Abstract

Marshall, D. P.; Sobol, I.; Horwitz, S.; Krishnan, U.; Abrams, J.; Zhang, C.; Mahmood, S. S.
Journal of the American College of Cardiology (2023)

Fulltext@MSK | Save

PI3K inhibitors in haematological malignancies

Correspondence

Matasar, M. J.; Hiemeyer, F.; Childs, B. H.; Zinzani, P. L.
Lancet Oncology (2022)

Fulltext@MSK | Save

Predictors of major hemorrhage after spleen core biopsy in cancer patients

Journal Article

Kunin, H.; Wijetunga, N. A.; Erinjeri, J. P.; Noy, A.; Deipolyi, A. R.
Journal of Vascular and Interventional Radiology (2022)

Fulltext@MSK | Save

Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: A single-arm, multicentre, phase 2 study

Journal Article

Budde, L. E.; Sehn, L. H.; Matasar, M.; Schuster, S. J.; Assouline, S.; Giri, P.; Kuruvilla, J.; Canales, M.; Dietrich, S.; Fay, K.; more...
Lancet Oncology (2022)

Fulltext@MSK | Save

Zandelisib with continuous or intermittent dosing as monotherapy or in combination with rituximab in patients with relapsed or refractory B-cell malignancy: A multicentre, first-in-patient, dose-escalation and dose-expansion, phase 1b trial

Journal Article

Pagel, J. M.; Soumerai, J. D.; Reddy, N.; Jagadeesh, D.; Stathis, A.; Asch, A.; Salman, H.; Kenkre, V. P.; Iasonos, A.; Llorin-Sangalang, J.; more...
Lancet Oncology (2022)

Fulltext@MSK | Save

Predictors of adequacy and adverse events during spleen biopsy in oncologic patients

Meeting Abstract

Kunin, H.; Wijetunga, N.; Erinjeri, J.; Noy, A.; Deipolyi, A.
Journal of Vascular and Interventional Radiology (2022)

Fulltext@MSK | Save

Reaching beyond maximum grade: Progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies

Review

Thanarajasingam, G.; Minasian, L. M.; Bhatnagar, V.; Cavalli, F.; De Claro, R. A.; Dueck, A. C.; El-Galaly, T. C.; Everest, N.; Geissler, J.; Gisselbrecht, C.; more...
The Lancet Haematology (2022)

Fulltext@MSK | Save

Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: A multicentre, single-arm, phase 2 trial

Journal Article

Soumerai, J. D.; Mato, A. R.; Dogan, A.; Seshan, V. E.; Joffe, E.; Flaherty, K.; Carter, J.; Hochberg, E.; Barnes, J. A.; Hamilton, A. M.; more...
The Lancet Haematology (2021)

Fulltext@MSK | Save